Khiron Life Sciences Stock Fundamentals

KHRWFDelisted Stock  USD 0  0.00  0.00%   
Khiron Life Sciences fundamentals help investors to digest information that contributes to Khiron Life's financial success or failures. It also enables traders to predict the movement of Khiron Pink Sheet. The fundamental analysis module provides a way to measure Khiron Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Khiron Life pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Khiron Life Sciences Company Return On Asset Analysis

Khiron Life's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Khiron Life Return On Asset

    
  -0.25  
Most of Khiron Life's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Khiron Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition
Based on the latest financial disclosure, Khiron Life Sciences has a Return On Asset of -0.2505. This is much lower than that of the sector and significantly lower than that of the Return On Asset industry. The return on asset for all United States stocks is notably higher than that of the company.

Khiron Life Sciences Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Khiron Life's current stock value. Our valuation model uses many indicators to compare Khiron Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Khiron Life competition to find correlations between indicators driving Khiron Life's intrinsic value. More Info.
Khiron Life Sciences is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Khiron Life by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Khiron Life's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Khiron Life's earnings, one of the primary drivers of an investment's value.

Khiron Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Khiron Life's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Khiron Life could also be used in its relative valuation, which is a method of valuing Khiron Life by comparing valuation metrics of similar companies.
Khiron Life is currently under evaluation in return on asset category among related companies.

Khiron Fundamentals

About Khiron Life Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Khiron Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Khiron Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Khiron Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America, North America, and Europe. Khiron Life Sciences Corp. was founded in 2017 and is based in Vancouver, Canada. Khiron Life is traded on OTC Exchange in the United States.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Consideration for investing in Khiron Pink Sheet

If you are still planning to invest in Khiron Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Khiron Life's history and understand the potential risks before investing.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios